Latest AI (Artificial Intelligence) News
AI Industrialization Reshapes Global Business in 2026
AI shifts from experimentation to core business operations, attracting nearly half of global startup funding last year. SMEs prioritize AI-first operations and cybersecurity, with 90% planning AI adoption amid rising digital risks.
2026 features a 'PLUTO' world of polarization, remilitarization, and economic realignment.
New BrainIAC AI Tool Predicts Brain Age, Dementia, and Cancer Survival
Harvard-affiliated researchers developed BrainIAC, an AI model trained on 49,000 brain MRIs to extract disease risks like brain age, dementia, and tumor mutations. It outperforms task-specific models using self-supervised learning, excelling with limited data across diverse scans.
The tool could accelerate biomarker discovery and personalize clinical care.
Global IT Spending to Hit $6.15 Trillion in 2026, Fueled by AI Infrastructure
Gartner forecasts 10.8% growth to $6.15 trillion, driven by hyperscalers' demand for AI-optimized servers despite bubble concerns. Generative AI model spending grows 80.8%, pushing software market over $1.4 trillion.
Data center systems lead the AI hardware surge.
AI Foundation Model Targets Predictable Stem Cell Therapies
Cellular Intelligence, co-founded by HMS researchers, builds an AI model on large biology datasets to enhance cell therapy scalability and predictability. It uncovers rules guiding cell development from stem cells, addressing reproducibility challenges.
The approach blends developmental biology, computation, and large-scale experiments.
AI Chip Market to Reach $1.1 Trillion by 2035 from $121B in 2026
Precedence Research projects 27.88% CAGR, driven by high-performance chips; U.S. market hits $37.49B in 2026. Governments invest heavily, like EU's €43B Chips Act and South Korea's low-power AI semiconductors.
Recent launches include Hyundai's low-power Edge Brain chips in January 2026.
OPENSCI Initiative Launches to Integrate AI in Global Science
World Laureates Association unveils AI-powered platform with blockchain for efficient scientific collaboration and value feedback. It supports autonomous reasoning agents amid AI accelerating discoveries like protein prediction.
Initiative addresses AI's data reliance on human experiments while reshaping research paradigms.
Nvidia and Eli Lilly Partner on AI Drug Discovery Lab
J.P. Morgan highlights AI's role in accelerating drug development via tech-pharma collaborations. Nvidia-Eli Lilly landmark partnership unites pharma research and computer science talents.
AI tools aim to relieve healthcare admin burdens and improve patient care.